Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk
American Heart Journal Mar 16, 2018
Lubitz SA, et al. - Factors associated with oral anticoagulation (OAC) non-prescription in patients with non-valvular atrial fibrillation (AF) at elevated stroke risk were determined using NCDR PINNACLE, a United States-based ambulatory cardiology registry. Data showed that among AF patients, treatment with OAC was commonly employed for older patients at elevated stroke and low bleeding risk. However, a variety of factors associated with OAC non-prescription included reversible AF etiology; female sex; liver, renal, or vascular disease; and physician versus non-physician provider. Specifically, antiplatelet use was prevalent and associated with the highest likelihood of OAC non-prescription.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries